Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.152.313.244.014.89

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 2.15 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.15
Mar20232.31
Mar20223.24
Mar20214.01
Mar20204.89

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2024 2.15
-6.93
Mar2023 2.31
-28.70
Mar2022 3.24
-19.20
Mar2021 4.01
-18.00
Mar2020 4.89 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹471.3 Cr 18.3% 16.6% -10.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,084.0 Cr -0% -4.6% 18.9% Stock Analytics
DIVIS LABORATORIES ₹162,384.0 Cr 8.8% 5.1% 64.4% Stock Analytics
CIPLA ₹118,853.0 Cr 2.4% -1.1% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,143.0 Cr 2.6% -9.9% -0.4% Stock Analytics
ZYDUS LIFESCIENCES ₹101,459.0 Cr 3.6% -0.1% 22.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

18.3%

16.6%

-10.2%

SENSEX

0.7%

-0.1%

8.8%


You may also like the below Video Courses